Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof

Details for Australian Patent Application No. 2006216695 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Bahar, Eliezer

Agent FB Rice

Pub. Number AU-A-2006216695

PCT Pub. Number WO2006/091656

Priority 60/656,866 24.02.05 US

Filing date 22 February 2006

Wipo publication date 31 August 2006

International Classifications

C07C 271/00 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

A61K 31/27 (2006.01)

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091656 Priority application(s): WO2006/091656

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216696-Rasagiline formulations of improved content uniformity

2006216694-Sealing container with stackable tops and bottoms